Contracts › W81XWH22P0051
W81XWH22P0051: Defibrinated Rabblit Blood 50 Ml
Awarded to Lampire Biological Labs Inc by Defense Health Agency.
$70Kobligated
$70Kpotential value
31 March 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81XWH22P0051 |
|---|---|
| Awardee | Lampire Biological Labs Inc |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 325414 Biological Product (Except Diagnostic) Manufacturing |
| PSC | 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Place of performance | PA |
| Offers received | 1 |
| Period of performance | 01 April 2022 to 31 March 2027 |
| Potential end | 31 March 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325414 contracts · All expiring contracts · USASpending record